TABLE 2.
Banff lesion grades in the antibody mediate rejection group, n (%).
| ABMR | ABMR | ||
| N | 18 | 18 | |
| g | C4d | ||
| 0 | 2 (11.1%) | 0 | 5 (27.8%) |
| 1 | 9 (50.0%) | 1 | 4 (22.2%) |
| 2 | 3 (16.7%) | 2 | 4 (22.2%) |
| 3 | 4 (22.2%) | 3 | 5 (27.8%) |
| ptc | cg | ||
| 0 | 1 (5.56%) | 0 | 11 (61.1%) |
| 1 | 8 (44.4%) | 1 | 4 (22.2%) |
| 2 | 8 (44.4%) | 2 | 1 (5.56%) |
| 3 | 1 (5.56%) | 3 | 2 (11.1%) |
| i | ci | ||
| 0 | 12 (66.7%) | 0 | 4 (22.2%) |
| 1 | 5 (27.8%) | 1 | 8 (44.4%) |
| 2 | 1 (5.56%) | 2 | 6 (33.3%) |
| 3 | 0 | 3 | 0 |
| t | ct | ||
| 0 | 10 (55.6%) | 0 | 5 (27.8%) |
| 1 | 7 (38.9%) | 1 | 7 (38.9%) |
| 2 | 1 (5.56%) | 2 | 6 (33.3%) |
| 3 | 0 | 3 | 0 |
| v | cv | ||
| 0 | 16 (88.9%) | 0 | 8 (44.4%) |
| 1 | 2 (11.1%) | 1 | 7 (38.9%) |
| 2 | 0 | 2 | 3 (16.7%) |
| 3 | 0 | 3 | 0 |
ABMR, antibody mediated rejection; cg, glomerular double contours; ci, Interstitial fibrosis; ct, tubular atrophy; cv, vascular fibrous intimal thickening; g, glomerulitis; i, inflammation; ptc, peritubular capillary; t, tubulitis; v, intimal arteritis.